FT : The unstoppable rise of Fortnox: Swedish software group attracts short sell

The unstoppable rise of Fortnox: Swedish software group attracts short sellers
Stock in $4.6bn company has boomed under chief executive Tommy Eklund. Analysts question how much further its niche business can expand

While some technology chief executives transform their industry, few have redefined it the way Tommy Eklund has at Fortnox.

Eklund has turned a niche supplier of accounting software that only operates in Sweden into a stock market sensation whose share price has risen fivefold on his watch.

Before he arrived in 2020, few predicted such stratospheric performance. The company had already signed up two-fifths of what Fortnox estimated were the country’s 800,000 small businesses comprising its “relevant market”.

Yet after a year under Eklund, Fortnox decided its total addressable market was actually 1.5mn businesses, more than that counted by Sweden’s statistical agency.

The discrepancy has attracted the attention of sceptical hedge funds and analysts, who wonder how Fortnox increased customer numbers and revenues with metronomic regularity, immune to trends in economic growth and a marked rise in bankruptcies; the firm added 10,000 customers in the third quarters of 2020, 2021, 2022 and 2023. 


At stake is the company’s $4.6bn market capitalisation, a 23x multiple of forecast sales that has made it one of the world’s most highly valued software groups, more expensive on that metric than Nvidia. 

Asked how Fortnox achieved such consistent growth, chief financial officer Roger Hartelius told the Financial Times the figures were “rounded to the nearest thousand”.

“The number is a net number and includes except new and churned customers also new via direct sales and via accounting firms but also newly started companies, as well as companies changing to one or more of our subscription products,” he wrote in response to questions.

Sweden’s statistics agency estimates there are 1,332,598 registered enterprises, including government agencies, of which 1mn were sole traders with no employees. 

Hartelius, who responded to questions sent to Eklund, said Fortnox viewed its market as 1.5mn organisations, including condominium associations and sports associations, which he said “are required to manage accounting and report to the tax office”. He also said that nuance was communicated at a 2021 investor day.

During that presentation Eklund said: “There are about 1.5mn businesses in Sweden right now and with this approach we think most of them are addressable.”


Some are sceptical. A sales report from broker Redburn last year said: “If it’s a private road with 20 houses collecting annual subscriptions, does it need bookkeeping software? Does it need to send out e-invoices? Perhaps not.”

Under Eklund, who describes the two-decade old company as a start-up, it has expanded in a number of business areas, including invoice financing, the purchase of a “marketplaces” division that connects consumers with professional contractors, and most recently corporate credit cards. 

From 2mn users of its services in 2020, Fortnox aims to hit 4mn by 2025, roughly two-thirds of Sweden’s working population. 

The Rule of Fortnox
A popular benchmark for software-as-a-service firms is a combined revenue growth rate and profit margin of at least 40 percentage points. If the company grows rapidly, profit margin theoretically becomes less important, but as it matures, executives need to make sure margins make up the shortfall. 

A metric at the heart of Eklund’s vision, which the company calls the “Rule of Fortnox” is a more ambitious 70 per cent. The company says it broadly achieved this for the last five years, and that it has been above 60 per cent for the past 11 quarters. 


Fortnox stock was a popular short for hedge funds over the past year, although some cut their positions after the share price jumped 18 per cent on Valentine’s Day, following the announcement of full-year results that beat market expectations.

The only current disclosed short seller is London-based hedge fund Marble Bar. Others to recently short the stock — but who have either exited their position or are below disclosure thresholds — include London’s Kuvari Partners, CapeView Capital, Shadowfall Capital and Research and the UK arm of JPMorgan Asset Management.

Eklund told investors that hiring staff to replace external consultants was a factor behind the jump in profit margins.   

As usual, Eklund took filtered questions on the earnings call moderated by an equity analyst, without the CFO. Hartelius said Eklund, with whom he worked at a previous company, was “doing a great job on the calls” and that “our financials are well described in our financial reports”.

Some investors challenge the quality of those reports, in which the presentation of its operating segments has changed every year under Eklund.

It now has five interrelated segments — businesses, accounting firms, core products, financial services and marketplaces — that sometimes sell on behalf of each other. 

Toby Clothier of Chameleon Global, which is short on Fortnox, said: “It should be incredibly simple and I can’t understand it, it looks like spaghetti junction. Who is paying who?”

Hartelius said “our main focus is on customers and products and the responsibility connected to that is how we have chosen to be organised”.

Fortnox also reduced disclosure around a business that lends to customers against the value of invoices. In the 2023 annual report released last week, details of money set aside for loan losses were reported as percentages rounded to the nearest whole number, rather than to a decimal point. 

For instance, loan loss provisions were 0.6 per cent in the 2022 annual report. In the 2023 version that figure became 1 per cent. Hartelius said the change “applies to all figures in our annual report due to our growth”. That document said the Fortnox effective tax rate was 15.8 per cent last year.

Growth incentives
Prospects for growth remain a central question. Fortnox says its core customer base is small businesses with between five and nine employees. Sweden’s statistics agency counted 46,000 businesses of this size in 2023, a small fraction of Fortnox’s 536,000 customers. 


“Going forward we are broadening our offer to be even better for smaller organisations, and moving into bigger organisations,” Hartelius said.

The rounded number of accountants using Fortnox was unchanged last year. “We think the Swedish market is significantly penetrated and that the remaining portion is sole traders, with revenue opportunities significantly smaller,” said one hedge fund shorting the company’s stock. 

Sweden’s tax authority said that out of 750,000 registered sole traders, about 180,000 reported no revenues in 2022. Eurostat’s estimate for the number of active businesses in Sweden is similar to Fortnox’s prior to Eklund’s arrival.

His incentives have been primarily tied to the share price, via an unusual arrangement in which Olof Hallrup, chair of the board and the company’s biggest shareholder, personally paid the Fortnox chief executive. 


Hallrup was convicted of insider trading in Fortnox stock ahead of a 2016 takeover bid by rival Visma. The purchase was blocked on competition grounds and Hallrup was then acquitted on appeal in 2018 and compensated for damages.

His company First Kraft issued 100,000 Fortnox call options of 10 shares each to Eklund on his appointment. First Kraft sold SKr600mn ($57mn) worth of stock early in 2023 to leave it with 18.8 per cent of Fortnox. A one-year commitment to refrain from further sales expired last month.

Hallrup also leases offices to Fortnox through another company that received SKr25mn ($2.3mn) of rent last year: more than the SKr23mn First Kraft received in dividends that year. Hallrup said he offered to build the office because he “was convinced that the development of the company would be significantly improved and that our profile in the community would be strengthened”, and that the rent was set below market value.

Hallrup’s incentive plan for Fortnox’s chief executive was a resounding success. Eklund exercised his options in 2022 at a strike price of SKr20. Had he retained them all his stake would be worth $7.4mn today, rather than the $2.6mn worth of shares he held at year end.  

FT : CitizenM owners explore potential sale of hotel group

CitizenM owners explore potential sale of hotel group
Boutique chain wants to expand and take advantage of post-pandemic travel boom

The owners of boutique hotel chain CitizenM are working with bankers to explore options for the business, including a potential sale, as it seeks to expand following a rebound in the travel sector post-pandemic.

Netherlands-based CitizenM’s owners including its largest shareholder Dutch pension provider APG, Singaporean wealth fund GIC and founder Rattan Chadha are being advised by Morgan Stanley and the real estate-focused advisory Eastdil Secured, according to people familiar with the matter.

GIC took a 25 per cent stake in CitizenM five years ago in a deal that valued the business at €2bn including debt. The company’s value had increased since then and it could now be worth roughly €4bn in a deal, one of the people said.

Deliberations were at an early stage and the company could also pursue the sale of a minority stake, one of the people said, cautioning that no final decision had been taken yet.

The company is exploring options to raise money from institutional investors to drive its continued expansion, as well as potentially allow for some existing investors to monetise their shareholdings.

When GIC bought into the company, CitizenM had 15 hotels. That number has since more than doubled and the group now has more than 40 locations and 10,000 rooms across North America, Europe and Asia.

The company currently has hotels under development in Boston, Miami and Dublin, according to its website. It claims it has higher profitability per square metre than other hotels because of its brand, design, centralised technology operations and standardised construction with rooms being prefabricated and shipped to the construction site.

Businesses in the travel and hospitality sectors have returned to dealmaking after the pandemic, following a travel boom last summer in Europe despite rising hotel and flight prices.

Saudi Arabia’s Public Investment Fund bought a 49 per cent stake in Sir Rocco Forte’s luxury hotel group in December with plans to double the chain’s size over the next five years with new hotels in the Middle East, Italy and the US.

Rattan Chadha, who is the company’s executive chair, started CitizenM — the “M” stands for “mobile” — in 2008 with specifically short-stay business travellers in mind.

The company was one of the first in a breed of micro hotels, alongside the likes of easyHotel and Yotel, which offer smaller rooms but larger meeting spaces and lobbies.

CitizenM, Eastdil, APG, GIC and Morgan Stanley declined to comment. Chadha’s investment group KRC Capital did not immediately respond to requests for comment.

WSJ : Merck’s $11.5 Billion Bet on Its Next Big Drug Finally Arrives

Merck’s $11.5 Billion Bet on Its Next Big Drug Finally Arrives
Newly approved medication treats potentially fatal pulmonary arterial hypertension

Merck MRK 0.17%increase; green up pointing triangle is making a big bet that its new drug, approved Tuesday in the U.S. for a potentially fatal lung disease, will take the company a long way toward heading off a massive revenue decline later this decade.

The drug, which will sell under the name Winrevair, treats a condition called pulmonary arterial hypertension that affects nearly 40,000 people in the U.S. In 2021, Merck paid $11.5 billion for the company developing the medicine. Some analysts estimate sales as high as $7.5 billion a year.

Merck is counting on the blockbuster performance. More than 40% of the drug company’s revenue, some $25 billion last year, comes from cancer treatment Keytruda. The immunotherapy is the world’s top-selling drug. Merck’s main U.S. patent for it expires in 2028, opening the door for lower-cost versions to eat into sales.

Winrevair will list for a price of $14,000 a vial, which for about two-thirds of patients will be the amount given every three weeks. That translates into about $242,000 for a full year, though Merck said the cost would vary by patient because dosage is weight-based.

“We see this as a multibillion-dollar potential opportunity for the company,” Merck Chief Executive Rob Davis said in an interview. “Over time we think we can move into earlier lines of therapy and potentially into much broader patient populations.”

Davis said progress in Merck’s research pipeline would help make the Keytruda loss of exclusivity “more of a hill than a cliff. And our confidence that we will be able to grow beyond that is high.”

The Food and Drug Administration approved Winrevair as an add-on therapy to other drugs for pulmonary arterial hypertension, which is commonly known as PAH.

The disease is a type of high blood pressure caused by constrictions in tiny arteries of the lungs. It causes shortness of breath and fatigue, diminishes exercise capacity and can be fatal without treatment. It is most common in women ages 30 to 60 years.

Winrevair, also known by its generic name sotatercept, uses a new approach to target the underlying cause of PAH. It works to stop the proliferation of cells in artery walls that lead to constrictions.

In a Phase 3 study, a sotatercept injection every three weeks significantly improved volunteers’ exercise capacity—measured by distance walked in six minutes—and extended the time until either death or disease progression, compared with a placebo.

“It’s a big breakthrough,” said Dr. Jessica Huston, a cardiologist at Ascension Saint Thomas Heart in Nashville, Tenn., who enrolled patients in the Merck-funded study. “It feels like this drug is finally something different than we’ve been doing all along, and is actually disease modifying.”

The drug was associated with side effects including bleeding and the formation of small blood vessels on the skin in some patients.

Its launch returns cardiovascular treatment to a prominent place at Rahway, N.J.-based Merck. The company’s first billion-dollar drug was Vasotec for high blood pressure. Mevacor was the first commercial statin for high cholesterol, and the company later sold the next-generation statin Zocor.

Merck also is hoping to preserve some Keytruda sales by testing whether its use in combination with other therapies works better than Keytruda alone. These include an experimental cancer vaccine developed by Moderna and a next-generation chemotherapy treatment called an antibody-drug conjugate.

Among its top drug prospects in the works are treatments for lung cancer and a pneumococcal vaccine for adults.

WSJ : Baltimore Bridge Crash Investigators to Examine Whether Dirty Fuel Played

Baltimore Bridge Crash Investigators to Examine Whether Dirty Fuel Played Role in Accident
Probe is just starting, but contaminated fuel can create problems with a ship’s main power generators

A safety probe into a Baltimore bridge collapse will include whether contaminated fuel played a role in a giant cargo ship losing power and crashing into the span, according to people familiar with the investigation.

Safety investigators hadn’t boarded the ship, called the Dali, late Tuesday afternoon while it remained stuck at a pillar of the collapsed Francis Scott Key Bridge. The vessel could remain in that location for weeks. Rescue crews spent much of Tuesday searching for potential survivors.

The lights on the Dali began to flicker about an hour after the ship began its voyage early Tuesday. A harbor pilot and assistant reported power issues and a loss of propulsion before the crash, according to a Coast Guard briefing report viewed by The Wall Street Journal.

“The vessel went dead, no steering power and no electronics,” said an officer aboard the ship Tuesday. “One of the engines coughed and then stopped. The smell of burned fuel was everywhere in the engine room and it was pitch black.” The ship didn’t have time to drop anchors to stop drifting, the officer said. Crew members issued a mayday call before the accident.

Blackouts at sea aren’t common, but they do happen and have long been considered a major accident risk for ships.

One cause is contaminated fuel that can create problems with the ship’s main power generators, said Fotis Pagoulatos, a naval architect in Athens. A complete blackout could result in a ship losing propulsion, he said. Smaller generators can kick in but they can’t carry all the functions of the main ones and take time to fire up.

The investigation will include reviews of the vessel’s operations and safety record as well as those of its owner and operator, said Jennifer Homendy, chair of the National Transportation Safety Board, during a press conference. Crews will look at securing recorders, similar to a plane’s black box, from the vessel to better understand what happened.

The agency didn’t comment on what issues investigators have uncovered so far in connection with the incident.

“This is a team effort,” said Homendy. “There are a lot of entities right now in the command post.”

The Dali was built in 2015 by South Korea’s Hyundai Heavy Industries. The Panamax-type ship, which can carry up to 10,000 containers, is an industry workhorse and one of thousands that regularly transit through the Panama and Suez Canals. While dwarfed by the biggest containerships, a vessel the Dali’s size is typical for U.S. ports on the East Coast. A few days before entering Baltimore’s harbor, the ship had stopped in Norfolk, Va.

The ship has had more than 20 port state control inspections—reviews of foreign ships in national ports—since it was built, according to data from Equasis, an international shipping database. None of the listed inspections resulted in a detention, which could occur when a ship is deemed unfit to travel.

Deficiencies were noted in two such reviews: one done in Belgium in July 2016 that noted hull damage and another in Chile in June 2023 that reported an issue with the ship’s propulsion and auxiliary machinery, Equasis data show. The U.S. Coast Guard completed an examination of the vessel in September 2023 and didn’t identify any issues.

On the voyage Tuesday, Singapore-based Synergy Marine Group operated the vessel and it was hauling cargo for Danish shipping giant A.P. Moller-Maersk MAERSK.B -2.64%decrease; red down pointing triangle. The nearly 1,000-foot-long ship departed from a terminal at the Port of Baltimore and was heading to Sri Lanka. A Singaporean company, Grace Ocean Pte., owns the ship.

Two tugboats helped the ship steer out of the terminal Tuesday, but they pulled back early in the voyage, according to port officials. There were two pilots and 22 crew members from India aboard the vessel during the crash, said Darrell Wilson, a spokesman for Synergy Marine.

The ship was moving around 9.2 mph, according to authorities, which is typical for vessels traveling in the area. Ships as large as the Dali need to maintain a certain speed to avoid being pushed around by winds and currents.

The bridge collapse is set to lead to a multibillion-dollar string of insurance claims, covering everything from the loss of the structure itself to the disruption to businesses using the port, insurance analysts said. The Francis Scott Key Bridge was built in 1977 at a cost more than $60 million, which is around $300 million today when adjusted for inflation. Victims of the crash could also file claims against the ship operator.

The scale and complicated nature of the losses mean litigation is inevitable, analysts and academics said.

“You can write off the next 10 years in court actions,” said Robert Merkin, a law professor at the University of Reading.

Reinsurers, which take on risks sold to them by insurers, “will bear the bulk of the insured cost,” said Mathilde Jakobsen, a senior director at ratings firm AM Best.

The ship’s insurer, Britannia P&I Club, belongs to a group of specialized marine insurers that have reinsurance cover of up to $3.1 billion per vessel. Britannia said it is working to “help ensure that this situation is dealt with quickly and professionally.”

Claims on the ship’s coverage could be complicated by quirks in marine insurance law, such as a convention that limits liability based on the ship’s value.

One of the biggest claims in recent years was associated with the Costa Concordia, a cruise ship that sank near an Italian island in 2012. Thirty-two people died in the incident, and insurers paid more than $2 billion to claimants, according to London-based marine insurers. The 2022 fire and sinking of the car carrier, Felicity Ace, resulted in more than $500 million paid out under insurance policies.

>>> US After Hours Summary: NCNO +11.9%, NOAH +3.8% higher on earnings; GME -14

After Hours Summary: NCNO +11.9%, NOAH +3.8% higher on earnings; GME -14.4%, CNXC -3% lower on earnings; MRK +4.8% as FDA approves Winrevair; ROIV +5% higher as it will join S&P MidCap 400

After Hours Gainers:

Companies trading higher in after hours in reaction to earnings/guidance: NCNO +11.9%, NOAH +3.8%, OUST +3.5%

Companies trading higher in after hours in reaction to news: STKS +16% (to acquire Safflower Holdings, owner of Benihana, for $365 mln), ROIV +5% (to join S&P MidCap 400), MRK +4.8% (FDA approves Winrevair), STOK +4.2% ($75 mln stock offering), BTBT +3.9% (customer proposes expansion by 2,048 GPUs), RUN +3.7% (to move to S&P SmallCap 600 from S&P MidCap 400), GPRO +3.6% (to reduce global workforce by 4%), ZVRA +2.8% (reports data from Phase 2 trial of KP1077), EAF +2.4% (names new CEO), MNKD +0.8% (CFO to retire; names new CFO), NVAX +0.8% (co and Fujifilm settle disputes), AZZ +0.1% (CFO to retire; names new CFO)

After Hours Losers:

Companies trading lower in after hours in reaction to earnings/guidance: GME -14.4% (also names new CFO), FRGE -10.5%, CNXC -3%

Companies trading lower in after hours in reaction to news: BWMN -11.1% (commences $50 mln public offering), ANNX -3.3% (files $400 mln mixed shelf securities offering; also reports Q4 results), MITT -0.8% (files $1 bln mixed shelf securities offering), NVO -0.3% (Obesity drug Zepbound on backorder across the US according to Bloomberg), RCKT -0.1% (names new CFO), ZUO -0.1% (files $400 mln convertible notes offering, relates to warrants), GD -0.1% (awarded $311 mln U.S. Navy contract)

>>> US Close Dow -0.08% S&P -0.28% Nasdaq -0.42% Russell -0.19%

Closing Stock Market Summary
The major indices closed at or near session lows, moving further from recent record highs. The market was trading higher for the majority of today's session before selling picked up in the late afternoon. The S&P 500 closed just above the 5,200 level, down 0.3% from yesterday.

The afternoon downturn coincided with some mega cap names and chipmakers either extending early losses or slipping into negative territory. Meta Platforms (META 495.89, -7.13, -1.4%), NVIDIA (NVDA 925.61, -24.41, -2.6%), and Broadcom (AVGO 1331.49, -20.09, -1.5%) were standouts in that respect. The Vanguard Mega Cap Growth ETF (MGK) fell 0.4% and the PHLX Semiconductor Index (SOX) slid 0.8%.

Still, downside moves were relatively modest, reflecting normal consolidation activity after a big run recently. The Invesco S&P 500 Equal Weight ETF (RSP) declined just 0.1%.

Only one of the S&P 500 sectors fell more than 1.0% -- utilities (-1.1%) -- while the health care (+0.3%), financial (+0.2%), and consumer staples (+0.1%) sectors logged gains. Aside from utilities, the energy (-0.8%) and information technology (-0.8%) sectors saw the largest declines.

Treasury yields initially moved higher in response to this morning's economic data, but ultimately settled lower. The 10-yr note yield was at 4.23% just before 8:30 ET, but moved as high as 4.27% today. It settled at 4.23%.

Market participants were reacting to an above-consensus Durable Orders report for February and a weaker than expected Consumer Confidence Index for March that was little changed from February's revised reading.

  • S&P 500:+9.1% YTD
  • Nasdaq Composite: +8.7% YTD
  • S&P Midcap 400: +7.3% YTD
  • Dow Jones Industrial Average: +4.2% YTD
  • Russell 2000: +2.1% YTD

Review today's economic data:
  • February Durable Orders 1.4% (Briefing.com consensus 1.3%); Prior was revised to -6.9% from -6.1%; February Durable Goods -ex transportation 0.5% (consensus 0.4%); Prior -0.3%
    • The key takeaway from the report is that business spending rebounded after a poor January as nondefense capital goods orders increased 4.4%.
  • January FHFA Housing Price Index -0.1%; Prior 0.1%
  • January S&P Case-Shiller Home Price Index 6.6% (consensus 6.7%); Prior was revised to 6.2% from 6.1%
  • March Consumer Confidence 104.7 (consensus 106.7); Prior was revised to 104.8 from 106.7
    • The key takeaway from the report is that it showed little overall change in sentiment, which has been consistent with the University of Michigan's Consumer Sentiment survey.

Wednesday's economic calendar includes:
  • 7:00 ET: Weekly MBA Mortgage Index (prior -1.6%)
  • 10:30 ET: Weekly crude oil inventories (prior -1.95 mln)

WSJ : Johnson & Johnson Considers Deal for Shockwave Medical

Johnson & Johnson Considers Deal for Shockwave Medical
Medical-devJohnson & Johnson JNJ 0.09%increase; green up pointing triangle is in talks to acquire the medical-device maker Shockwave Medical SWAV 8.38%increase; green up pointing triangle.

A deal could be finalized in the coming weeks, assuming talks don’t fall apart, according to people familiar with the matter. It is also possible another suitor could emerge.

Any deal would be sizable, given that Shockwave has a market value of about $11 billion after its stock has surged roughly 50% so far this year.

Johnson & Johnson has a market capitalization of around $375 billion. ices maker has a market value of about $11 billion